Related Experiment Videos
Drug prevention and HIV policy
R Power1, G V Stimson, J Strang
1Centre for Research on Drugs and Health Behaviour, Charing Cross & Westminster Medical School, University of London, UK.
AIDS (London, England)
|January 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.
The International journal on drug policy·2022
Undetected Respiratory Depression in People with Opioid Use Disorder.
Drug and alcohol dependence·2022
Dystrophic calcinosis cutis successfully treated with extracorporeal shockwave lithotripsy.
Clinical and experimental dermatology·2021
Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.
AIDS (London, England)·2026
Two-year efficacy and safety of long-acting cabotegravir and rilpivirine in the SCohoLART study.
AIDS (London, England)·2026
Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care.
AIDS (London, England)·2026
Nurse-led education to improve deep vein thrombosis prevention knowledge after hip arthroplasty: a sequential controlled quasi-experimental study.
International journal of orthopaedic and trauma nursing·2026
Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.
Frontiers in public health·2026
Capitalizing on change: Habitus transformation and cancer mitigation in the field of firefighting.
Social science & medicine (1982)·2026